Case Reports

Clonal CD8+ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma

Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; UMR 996 INSERM, Inflammation Microbiome and Immunosurveillance, Paris-Saclay University, Orsay
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; Université Paris Cité, CNRS, INSERM, UTCBS, Unité des technologies Chimiques et Biologiques pour la Santé, Paris
Department of Rheumatology, Université Paris Saclay, FHU CARE, INSERM UMR1184, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Paris-Saclay University, Faculty of Medicine, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre
Haematologica Early view Mar 28, 2024 https://doi.org/10.3324/haematol.2023.284942